Filing Details
- Accession Number:
- 0001209191-20-050755
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-16 18:01:24
- Reporting Period:
- 2020-09-14
- Accepted Time:
- 2020-09-16 18:01:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
718937 | Staar Surgical Co | STAA | Ophthalmic Goods (3851) | 953797439 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1678691 | Keith Holliday | 25651 Atlantic Ocean Drive Lake Forest CA 92630 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-09-14 | 1,286 | $7.52 | 29,733 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-09-14 | 21,294 | $9.30 | 51,027 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-09-14 | 3,994 | $16.15 | 55,021 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-09-14 | 26,574 | $53.26 | 28,447 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-09-14 | 9,115 | $53.49 | 19,332 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-09-15 | 13,217 | $16.15 | 32,549 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-09-15 | 10,112 | $29.80 | 42,661 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-09-15 | 12,997 | $35.98 | 55,658 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-09-15 | 36,326 | $53.33 | 19,332 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock Options | Disposition | 2020-09-14 | 1,286 | $0.00 | 1,286 | $7.52 |
Common Stock | Common Stock Options | Disposition | 2020-09-14 | 21,294 | $0.00 | 21,294 | $9.30 |
Common Stock | Common Stock Options | Disposition | 2020-09-14 | 3,994 | $0.00 | 3,994 | $16.15 |
Common Stock | Common Stock Options | Disposition | 2020-09-15 | 13,217 | $0.00 | 13,217 | $16.15 |
Common Stock | Common Stock Options | Disposition | 2020-09-15 | 10,112 | $0.00 | 10,112 | $29.80 |
Common Stock | Common Stock Options | Disposition | 2020-09-15 | 12,997 | $0.00 | 12,997 | $35.98 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
23,714 | 2017-03-18 | 2026-03-17 | No | 4 | M | Direct |
16,206 | 2018-03-21 | 2027-03-20 | No | 4 | M | Direct |
21,006 | 2019-03-15 | 2028-03-14 | No | 4 | M | Direct |
7,789 | 2019-03-15 | 2028-03-14 | No | 4 | M | Direct |
3,372 | 2019-06-14 | 2028-06-13 | No | 4 | M | Direct |
12,998 | 2020-03-14 | 2029-03-13 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.07 to $53.97, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.25 to $54.06, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.02 to $53.71, inclusive.
- The options granted become exercisable as follows: 1/3 on 3/15/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/15/2021.
- The options granted become exercisable as follows: 1/3 on 6/14/2019 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 6/14/2021.
- The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.